Medindia
Medindia LOGIN REGISTER
Advertisement

Zicam(R) Cold Remedy to Sponsor ING New York City Marathon 2007

Wednesday, October 31, 2007 General News
Advertisement
NEW YORK, Oct. 30 Matrixx Initiatives, Inc.(Nasdaq: MTXX), today announced that Zicam(R) Cold Remedy will be the officialhomeopathic cold remedy of the ING New York City Marathon.
Advertisement

(Photo: http://www.newscom.com/cgi-bin/prnh/20071030/NYTU030 )

Matrixx Initiatives, Inc. will be exhibiting at the ING New York CityMarathon Health and Fitness Expo at the Jacob Javits Convention Center,November 1-3, booth number 535. Chris Carmichael, best-selling author andcoach to seven-time Tour-De-France winner Lance Armstrong, will be on hand tomeet with attendees and offer fitness advice. Visitors to the Matrixx boothwill receive free Zicam samples and information as well as have theopportunity to enter into a drawing to win a signed copy of Carmichael'slatest book, 5 Essentials for a Winning Life.
Advertisement

"We are proud to sponsor the ING New York City Marathon, an event whichenables us to reach so many professional and recreational athletes," said TimConnors, Vice President of marketing, Matrixx Initiatives, Inc. "Zicam ColdRemedy is perfect for anyone with an active lifestyle - from Olympic hopefulsto moms on the go, because it is clinically proven to lessen the severity ofcold symptoms and shorten the duration of the cold when taken within the first24-48 hours after symptom onset."

According to Connors, Zicam Cold Remedy products do not contain bannedsubstances, have no known drug interactions, and will not cause anxiety ordrowsiness.

"When training for a major athletic endurance event, the rule of thumb isone week off equates to two to three weeks of lost fitness," said Carmichael."Zicam Cold Remedy can help prevent spoilers like the common cold from ruininga big event that you've worked hard for, such as a marathon or an importantbusiness meeting."

The ING New York City Marathon is the premier event of New York RoadRunners. This year, more than 37,000 runners from all 50 states and over 100countries will participate. Race day is Sunday, November 4, 2007.

About Matrixx Initiatives, Inc.

Matrixx Initiatives, Inc. is engaged in the development, manufacture andmarketing of over-the-counter healthcare products that utilize innovative drugdelivery systems. Zicam, LLC, its wholly-owned subsidiary, produces, marketsand sells Zicam(R) products in the cough and cold category. The Company'sflagship product, Zicam Cold Remedy nasal gel, is a patented, homeopathicremedy that has been clinically proven to reduce the duration and severity ofthe common cold. In studies published in the October 2000 issue of ENT -- Ear,Nose and Throat Journal, and separately in the January 2003 issue of QJM: AnInternational Journal of Medicine, the Zicam Cold Remedy product was shown toreduce the duration of the common cold. The Company also manufactures andmarkets a full line of Zicam brand pharmaceuticals, including Zicam ColdRemedy in five oral delivery forms; three Zicam allergy and congestion reliefproducts; as well as Zicam Cough products and Zicam Multi-Symptom reliefitems; and two Nasal Comfort products. For more information regarding Matrixxproducts, go to www.Zicam.com

About New York Road Runners

New York Road Runners, soon to celebrate its 50th anniversary, isdedicated to promoting the sport of distance running, enhancing health andfitness for all, and responding to community needs. Our road races and otherfitness programs draw upwards of 300,000 runners annually, and together withour magazine and website support and promote professional and recreationalrunning. A staff of more than 100, assisted by thousands of volunteers, stagesthe ING New York City Marathon, as well as a road race nearly every weekendplus many track and cross country events. NYRR's home base in New York, andits lifelong identification with Central Park, have given many of its eventsiconic status, attracting the world's top professional runners. Our youth
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close